Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
about
The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System TumorsInhibition of 13-cis retinoic acid-induced gene expression of reactive-resistance genes by thalidomide in glioblastoma tumours in vivoRecent advances and future of immunotherapy for glioblastoma.COX-2 expression positively correlates with PD-L1 expression in human melanoma cells.Developing immunotherapeutic strategies to target brain tumors.Cyclooxygenase-2 in glioblastoma multiforme.Factorial clinical trials: a new approach to phase II neuro-oncology studies.Recognition by natural killer cells of N6-isopentenyladenosine-treated human glioma cell lines.FM19G11 inhibits O6 -methylguanine DNA-methyltransferase expression under both hypoxic and normoxic conditions.Effects of tumor grade and dexamethasone on myeloid cells in patients with gliomaTraffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapyDrug Repurposing of Metabolic Agents in Malignant Glioma
P2860
Q28087476-B9E7DF77-2CAE-4B84-8A04-DE73150F768EQ36557180-4FE2BD41-2345-4985-852D-7B7B21DD3E75Q37239071-9C5DA1D1-89E7-4A95-B91C-2CEEDEC01E91Q37663388-2DB98320-4E6C-4698-A769-A14EDB55D93CQ38851464-1C49B0E6-7F4A-439B-8A32-0E7ECEBE2F2FQ38969912-F274EC93-A589-4DE5-A82F-88B87FDF0BBEQ43098246-30B4E341-4A32-45BC-BCF5-37CB494667CFQ47836415-ACD06244-6426-4215-B236-896BF36D563EQ53682260-0A612F22-28B1-4729-BC4D-F3451AC027F8Q58129521-076A23FF-0638-4A0E-9C97-385C1670EC81Q58544569-A03A45BD-84FF-427B-825B-C8E058DFAEB3Q58738611-9B497DF6-78D1-4F18-9ADD-31DC0CABE743
P2860
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@ast
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@en
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@nl
type
label
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@ast
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@en
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@nl
prefLabel
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@ast
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@en
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@nl
P2093
P2860
P356
P1433
P1476
Randomized phase II adjuvant f ...... thalidomide for glioblastoma.
@en
P2093
Anita Mahajan
Brain Tumor Trials Collaborative
Charles A Conrad
Eric L Chang
Gena Volas-Redd
Howard Colman
Javier Gonzalez
John F De Groot
Justin D Floyd
Kenneth D Aldape
P2860
P304
P356
10.1093/NEUONC/NOU155
P577
2014-09-19T00:00:00Z